As we continue to fight the impact of #lungcancer on society and health systems, integrating #AI-powered incidental pulmonary nodule detection from routine chest X-rays offers a promising avenue to complement traditional CT-based screening methods. By casting a wider net and empowering clinicians with advanced tools to identify early signs of lung cancer, we can work towards reducing the burden of this deadly disease and improving patient outcomes worldwide. Find out how the use of X-ray AI for incidental detection of lung anomalies help boost early detection of #lungcancer - https://lnkd.in/dYGHhw_A Bhargava Reddy Anumeha Srivastava Ranjana Devi Sagar Sen Preetham Putha Samir Shah, MD, MMM FACR Nate Hunter Dhruv Pandey Chris Pordon Georgina Wright Ramakrishna Bhimana Amisha Panchal Rakhee Krishnan Daniel Lehewych Bunty Kundnani
Qure.ai
Medical Device
Our mission is to make healthcare more affordable and accessible through the power of Artificial Intelligence
About us
Qure.ai is a health tech company that uses deep learning and Artificial Intelligence (AI) to make healthcare more accessible and equitable for patients worldwide. Our solutions power the efficient identification and management of Tuberculosis (TB), Lung Cancer and Stroke to support clinicians and propel developments in the pharmaceutical and medical device industries. We empower healthcare by helping to identify conditions fast, prioritize treatment planning and ultimately improve the quality of patient life.
- Website
-
http://www.qure.ai
External link for Qure.ai
- Industry
- Medical Device
- Company size
- 51-200 employees
- Headquarters
- New York
- Type
- Privately Held
- Founded
- 2016
- Specialties
- Deep learning, Healthcare, Digital Radiology, Medical Imaging, Artificial Intelligence, Workflow Optimisation, Lung Health, Heart Failure, MSK, Neuro Critical Care, and lung cancer
Locations
-
Primary
Qure.ai Technologies Inc
New York , US
Employees at Qure.ai
Updates
-
Listen to Dr. Rena Fukunaga from the Centers for Disease Control and Prevention, US; Dr. Emperor Ubochioma from NTBLCP: Jai Bassi from Qure.ai; and Chidimma Okoye from Caritas Nigeria speak on “The Use of #AI-enabled Portable Digital X-Ray Machines for Integrated Screening of #Tuberculosis, Cardiovascular Diseases, and Chronic Respiratory Diseases in Communities: Lessons Learned and New Opportunities” on Tuesday, July 30, 2024, from 12:00 PM to 1:15 PM (GMT 1) / 5:30 PM to 6:45 PM IST. Register here for the event: https://lnkd.in/d2Bgr5bX Prashant Warier Dr. Pragnesh Pokar Sruti Sridhar Justy Antony Chiramal Mangesh Ashrit Shibu Vijayan Divya Gupta Dara Kelleher Ankit Modi Justy Antony Chiramal Bhargava Reddy Anumeha Srivastava Jai Bassi Yakhouba TOURÉ Ronika Susan George Kingshuk Misra Somesh Pathak Sanya Chawla Kautuk Trivedi Khalid Hegazy, MBA Saniya Pawar Suridhi Sharma Shreshth Bansal Nimmy Dominic
-
-
Qure.ai reposted this
🇩🇪 Next week, I will be attending the International AIDS Conference in Munich. If you’ll be there, I’d love to meet. Over the 6 months since I joined Qure.ai, I have had hundreds of conversations with heath-workers, patients, government officials and NGO leaders on the collective resolve to deliver #integrated, #peoplecentred #healthcare. A system of care designed around people, rather than diseases, which recognises that when diseases like #TB and #HIV so often co-exist in the human body, their diagnosis and treatment pathways must, too, co-exist in the same architectural spaces, hospital wings and clinics. They must also co-exist in the minds of health-workers, programme designers and funders, and in the #technologies supporting care and tackling common, often socio-economic, drivers of illness. What has been hammered home for me while visiting health-centres over these last months – from the colourful bungalow of a Community Health Worker, doubling as a screening clinic in northern #Lima, to a quiet side room in a bustling central #Addis hospital – is that ‘integrated care’ means #simplification: care in one place, at one time. For patients it means fast answers to save the agony of waiting for life-altering results, or the economic impact of losing a day’s wages to travel to multiple clinics for vital information and prescriptions. In a recent Devex article, Timur Abdullaev, TB Activist and Consultant for the Stop TB Partnership, put it in strikingly practical terms, describing the impact of a new #digital #Xray machine being installed in the AIDS centre he attends, to test for TB: “It wasn’t there 10 years ago and it’s amazing that they have it now,” he said. “As a person with HIV, I love that I don’t need to go to another place to do the X-ray.” A seemingly simple #innovation, the likes of which are surely reducing the patient loss-to-follow-up which contributes to 30% of #AIDS-related deaths attributed to TB. It’s so exciting to me at Qure.ai to witness these simplifications at work – the rural Community Health Worker providing peer-support to her patient living with HIV who can now use our #AI to screen for TB, or the clinician in an over-burdened hospital empowered with rapid screening data to enable an on-the-spot referral. We know how to #prevent and #treat both diseases. It’s about removing the frictions which stop patients accessing that care. Hundreds more conversations to be had, and solutions implemented, to address these obstacles. Looking forward to continuing the conversations in #Munich – hope to see you there! International AIDS Society, Private Sector Constituency to Stop TB Partnership, Socios En Salud, mothers2mothers, Prashant Warier, Dara Kelleher, Shibu Vijayan, Ronika Susan George, Kingshuk Misra, Divya Gupta, Shreshth Bansal, Emma France, Afua Basoah, DPhil, FRSA, David Gallagher, Luisa Engel, Greg Sheps, Andrew Cross, Mario Ottiglio, Dillon Mann, Morgane Legendre Arber #integrated #healthcare
-
-
https://lnkd.in/dr5rb8FX Dr. Shibu Vijayan, Chief Medical Officer of Global Health at Qure.ai, and Dr. Jeremiah Dr. Chakaya, a founding member of the Respiratory Society of Kenya (ReSok), discussed the potential of digitalization, multiplexing, and accuracy in identifying underlying conditions to address #lunghealth and #TB control in this Qureosity episode. They emphasized the need to develop new products and tools to assist clinicians and build models for integrated care using global funds. They also highlighted the potential of digital solutions to identify the underlying causes of conditions and end TB by 2030. Let’s have a look at what Dr. Chakaya discusses in this Qureosity episode. Stop TB Partnership UHC2030 - Taking action for universal health coverage The Global Fund USAID African Society for Laboratory Medicine (ASLM) International Union Against Tuberculosis and Lung Disease (The Union) Bill & Melinda Gates Foundation World Health Organization (WHO) TBPPM Learning Network Bhargava Reddy Anumeha Srivastava Dara Kelleher Kingshuk Misra Ronika Susan George Jai Bassi Cherechi Onuoha Yakhouba TOURÉ Sanya Chawla Suridhi Sharma #Healthcare #SDGGoals #LungHealth #GlobalHealth #TBCare #AIInHealthcare #SouthAfrica
-
Read our latest blog now: https://lnkd.in/dpPmqJv8 #Silicosis, a silent threat in mining communities, often remains undetected for years. This delay in detection not only impacts #health outcomes but also complicates the process of filing essential claims. However, there's hope on the horizon! #ArtificialIntelligence is revolutionising the way we approach silicosis detection and management. By analysing decades of medical imaging data, #AI algorithms can identify subtle signs of silicosis earlier than traditional methods, years before their symptoms manifest. At Qure.ai, we're committed to exploring these advancements and their impact on occupational health. Discover more about AI's role in transforming silicosis management and join the conversation today! Prashant Warier Dr. Pragnesh Pokar Sruti Sridhar Justy Antony Chiramal Mangesh Ashrit Shibu Vijayan Divya Gupta Dara Kelleher Ankit Modi Justy Antony Chiramal Bhargava Reddy Anumeha Srivastava Jai Bassi Yakhouba TOURÉ Ronika Susan George Kingshuk Misra Somesh Pathak Sanya Chawla Kautuk Trivedi Khalid Hegazy, MBA Saniya Pawar Suridhi Sharma Shreshth Bansal Nimmy Dominic #silicasafety #WorkplaceHealth #deathbydust #miningindustry #hazardousdusts #workingenvironment #respirablecrystallinesilica #silicadust #respiratoryprotection
-
News! Health Canada | Santé Canada has approved the Qure.ai portfolio of #medicalimaging #artificialintelligence solutions granting it a Class III medical device licence 🎯 . This will enable expansion into the Canadian #healthcare market to support clinicians and boost patient care. 👉 AI to optimize #lungcancer pathways via chest X-ray #AI to detect and localize lung nodules PLUS chest CT AI to empower screening programs and track lung nodule growth as part of progression monitoring. 👉 AI to triage neurocritical CT scans for the rapid detection of #stroke, traumatic brain injuries, and other neurological conditions in hospital emergency or teleradiology settings. Link to the news: https://lnkd.in/du8S3Smw Bhargava Reddy Anumeha Srivastava Ranjana Devi Sagar Sen Preetham Putha Bunty Kundnani Samir Shah, MD, MMM FACR Nate Hunter Dhruv Pandey Chris Pordon Georgina Wright Ramakrishna Bhimana Daniel Lehewych Rakhee Krishnan Amisha Panchal #HealthcareInnovation #AIInHealthcare #MedicalDevice #PatientCare #DigitalHealthcareTransformation
Qure.ai Receives Class III License from Health Canada
qure.ai
-
Today is #WorldBrainDay2024. With a focus on Brain Health and Prevention, we figured the best way to commemorate the occasion was to tell you about #qER, Qure’s #AI-powered Head CT solution. qER is globally proven – because AI biases can emerge if algorithms are not validated across diverse populations. But qER has been rigorously tested with multi-regional data, ensuring reliability globally. In North America, the #FDA-cleared qER quickly triages, detects, and quantifies critical head CT markers, achieving an AUC of 0.96 and significantly reducing interpretation times. In India, qER’s accuracy in detecting urgent CT abnormalities is validated by The Lancet, with AUC values of 0.92 for intracranial hemorrhage, and it significantly reduces symptom-to-treatment times in remote areas. In Europe, qER’s automated hematoma volume quantification for intracerebral hemorrhage shows 97% sensitivity and high concordance with manual methods. The UK’s NHS widely adopts qER, processing over 1 million emergency scans annually, achieving AUC scores above 0.95, and enhancing diagnostic accuracy. qER’s global integration accelerates emergency response times, facilitates timely interventions, and revolutionizes #healthcare delivery through AI-driven measurements, improving outcomes for neurological conditions worldwide. Read more about it in our blog: https://lnkd.in/gqUH6naC Anumeha Srivastava Dr. Tamaghna Ghosh Tara Naib, MBA Aradhana Kumar Kunal Wadhwa Dr.Namrata Singh Ramakrishna Bhimana Rakhee Krishnan Girish Umamaheshwar Nishita Chakraborty
Qure.ai's qER: Reliable AI for Head CT Scans Worldwide
qure.ai
-
Meet Qure.ai's Enla Fees at the International AIDS Conference in Munich this week, and explore the impact of #AI solutions on the TB-HIV coinfection burden. According to the World Health Organization, people living with HIV are most at risk of a fatal #TB infection, and 14 to 18 times more likely to get TB. It is critical in #healthcare programs for the two to go hand in hand. People with HIV should be screened for TB, and vice versa. However, there remains a gap in many healthcare centres, where the two departments are separate or in different rooms, leading to patients being missed in the process. At Qure, we are working towards integrated care pathways for healthcare providers, so they can access the best health-tech solutions and much-needed seamless support. To learn more about how you can integrate our TB care pathways into your HIV programs, reach out to us. Let’s ensure no patient is left behind. Prashant Warier Dr. Pragnesh Pokar Sruti Sridhar Justy Antony Chiramal Mangesh Ashrit Shibu Vijayan Divya Gupta Dara Kelleher Ankit Modi Justy Antony Chiramal Bhargava Reddy Anumeha Srivastava Jai Bassi Yakhouba TOURÉ Ronika Susan George Kingshuk Misra Somesh Pathak Sanya Chawla Kautuk Trivedi Khalid Hegazy, MBA Saniya Pawar Suridhi Sharma Shreshth Bansal
-
-
In 1964, the US Surgeon General declared that “cigarettes cause cancer”. This helped halt escalating tobacco use rates but decades before the ‘Marlboro Man’ advertisement made filtered cigarettes acceptable to men, not just women to smoke. Fast-track to the present day, #lungcancer is the leading cause of cancer-related deaths worldwide, five out of the twelve men who portrayed the Marlboro Man have died of lung disease and the ad campaign's target generation is now eligible for lung cancer screening themselves. Despite the availability of proactive CT-based lung cancer screening in the US, in some states such as California and Nevada, screening rates are as low as 1.0% and 1.3%. Could the macho Marlboro Man persona somehow be to blame for low lung cancer screening uptake rates? And could the innovation of chest X-ray #AI hold the key? Read on and find out more here: https://lnkd.in/dYGHhw_A Bhargava Reddy Ranjana Devi Sagar Sen Preetham Putha Samir Shah, MD, MMM FACR Nate Hunter Dhruv Pandey Chris Pordon Georgina Wright Aman Garg Ketaki Kakade Amisha Panchal Rakhee Krishnan Daniel Lehewych
AI and Lung Cancer Screening for the Marlboro Man Generation
qure.ai
-
Proud to have reached the halfway point of 5 million AI-assisted chest X-rays! Together with #AstraZeneca and the WEF EDISON Alliance, we're making strides towards early risk detection and improved survival rates for lung cancer. Let’s continue our collective effort to close the #lungcancer care gap by prioritising screening and early risk detection. Bhargava Reddy Ranjana Devi Sagar Sen Preetham Putha Samir Shah, MD, MMM FACR Nate Hunter Dhruv Pandey Chris Pordon Georgina Wright Aman Garg Ketaki Kakade Amisha Panchal Rakhee Krishnan Akhilesh D S N #LungCancerAwareness #AIInHealthcare
Through our partnership with the WEF EDISON Alliance, we committed to screen 5 million patients through AI-assisted chest X-rays that enable us to optimise and increase lung cancer screening and early detection. By the middle of June this year, we reached the milestone of 2.5 million AI-assisted chest X-rays scans across the world, with our partner Qure.ai and healthcare institutions around the world. While this is a noteworthy milestone to commemorate, a lot more needs to be done to drive a shift towards Lung Cancer detection at earlier stages, hence improving the chance for survival. We call upon on the global oncology community to come together, in a concerted effort to close the Lung Cancer care gap by making Screening & Early Detection a priority.
-